Price Capital Management Inc. Acquires Shares of 5,560 CME Group Inc. (NASDAQ:CME)

Price Capital Management Inc. purchased a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 5,560 shares of the financial services provider's stock, valued at approximately $1,475,000. CME Group makes up about 3.7% of Price Capital Management Inc.'s holdings, making the stock its 15th biggest position.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wayfinding Financial LLC acquired a new position in CME Group in the 1st quarter valued at about $25,000. Cornerstone Planning Group LLC grew its position in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares in the last quarter. New Age Alpha Advisors LLC grew its position in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares in the last quarter. Golden State Wealth Management LLC grew its position in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Finally, Alpine Bank Wealth Management acquired a new position in shares of CME Group during the 1st quarter worth approximately $32,000. 87.75% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CME. Morgan Stanley upped their price target on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. UBS Group reaffirmed a "neutral" rating and set a $305.00 price target on shares of CME Group in a report on Thursday. JPMorgan Chase & Co. cut their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Finally, Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $261.93.

CME Group Stock Up 0.9%

Shares of CME traded up $2.37 during trading hours on Friday, reaching $279.55. 1,834,736 shares of the stock traded hands, compared to its average volume of 2,117,443. The company has a market cap of $100.74 billion, a price-to-earnings ratio of 27.06, a PEG ratio of 4.85 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $193.25 and a 52 week high of $290.79. The stock has a fifty day simple moving average of $276.44 and a 200 day simple moving average of $262.25.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.56 earnings per share. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.79%. CME Group's payout ratio is 48.40%.

Insider Transactions at CME Group

In other news, Director Dennis Suskind sold 1,000 shares of CME Group stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the transaction, the director owned 2,915 shares in the company, valued at $790,781.20. This trade represents a 25.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the transaction, the director directly owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This represents a 12.00% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,400 shares of company stock valued at $3,152,410. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.